Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb This Week: CeGaT, Interpace Diagnostics, and GenBank

CeGaT Diagnostic Panel Update

CeGaT has launched an update of its diagnostics panel for epilepsy, metabolic, and brain development disorders. The update combines all three areas of disease on one gene panel, and includes 639 genes, divided into 28 gene-sets according to their clinical importance for each single area of disease. The panel was also adjusted to increase sequencing coverage within clinically relevant areas, the company said.

Interpace Diagnostics AccuCea Insights

Interpace Diagnostics has launched AccuCea Insights, a diagnostic testing service that aids in diagnosing and treating pancreatic cancer. The service provides physicians with additional information on how to compare diagnostic test results to those of other patients through Interpace's database of over 15,000 patients, the company said. Once reports are delivered to ordering physicians, they have an opportunity to speak with one of the company's molecular pathologists to discuss the potential benefits of conducting a full, molecular pathology review.

GenBank 215

GenBank 215 is now available via ftp from the National Center for Biotechnology Information. Uncompressed flatfiles in this release require 790 gigabytes for sequence files only. The ASN.1 data requires approximately 650 GB.

For more new products and services, please visit the New Products page on our website.